Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tarek Assi

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Immunotherapy|August 16, 2023
Ipilimumab and nivolumab: the 'new kid on the block' in advanced angiosarcomaTarek Assi, Rebecca Ibrahim, Toni Ibrahim, et al.
Critical Reviews in Oncology/Hematology|September 11, 2018
A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma originJoseph Kattan, Elie El Rassy, Tarek Assi, et al.
Future Oncology (London, England)|March 22, 2023
<i>KRAS</i> G12C mutation: from black sheep to key player in pancreatic cancer treatmentRebecca Ibrahim, Rita Khoury, Tony Ibrahim, et al.
The Gulf Journal of Oncology|January 12, 2021
Current Status of Cancer-Related Pain and Opioid use in South Lebanon: A Pilot StudyFadi S Farhat, Mohamed Tarabey, Feras Chehade, et al.
Critical Reviews in Oncology/Hematology|February 2, 2024
UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?Rebecca Ibrahim, Rita Khoury, Tony Ibrahim, et al.
Immunotherapy|June 13, 2019
The interaction of immune checkpoint inhibitor plus chemotherapy in non-small-cell lung cancer: subadditivity, additivity or synergism?Elie Rassy, Ziad Bakouny, Tarek Assi, et al.
Future Oncology (London, England)|May 2, 2023
NALIRIFOX in the upfront setting of metastatic pancreatic cancer: can FOLFIRINOX finally be dethroned?Rita Khoury, Rebecca Ibrahim, Tony Ibrahim, et al.
Anti-Cancer Drugs|August 18, 2017
Response of an ovarian granulosa cell tumor with everolimus and exemestane after initial response to letrozoleTarek Assi, Hampig R Kourie, Elie El Rassy, et al.
Clinics and Research in Hepatology and Gastroenterology|February 21, 2017
Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysisElie El Rassy, Tarek Assi, Fadi El Karak, et al.
Immunotherapy|July 17, 2018
Do immune checkpoint inhibitors perform identically in patients with weight extremes?Elie El Rassy, Marwan Ghosn, Nathalie Al Rassy, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Immunotherapy|August 16, 2023
Ipilimumab and nivolumab: the 'new kid on the block' in advanced angiosarcomaTarek Assi, Rebecca Ibrahim, Toni Ibrahim, et al.
Critical Reviews in Oncology/Hematology|September 11, 2018
A comprehensive review of the role of immune checkpoint inhibitors in brain metastasis of renal cell carcinoma originJoseph Kattan, Elie El Rassy, Tarek Assi, et al.
Future Oncology (London, England)|March 22, 2023
<i>KRAS</i> G12C mutation: from black sheep to key player in pancreatic cancer treatmentRebecca Ibrahim, Rita Khoury, Tony Ibrahim, et al.
The Gulf Journal of Oncology|January 12, 2021
Current Status of Cancer-Related Pain and Opioid use in South Lebanon: A Pilot StudyFadi S Farhat, Mohamed Tarabey, Feras Chehade, et al.
Critical Reviews in Oncology/Hematology|February 2, 2024
UGT1A1 Testing in Breast Cancer: should it become routine practice in patients treated with antibody-drug conjugates?Rebecca Ibrahim, Rita Khoury, Tony Ibrahim, et al.
Immunotherapy|June 13, 2019
The interaction of immune checkpoint inhibitor plus chemotherapy in non-small-cell lung cancer: subadditivity, additivity or synergism?Elie Rassy, Ziad Bakouny, Tarek Assi, et al.
Future Oncology (London, England)|May 2, 2023
NALIRIFOX in the upfront setting of metastatic pancreatic cancer: can FOLFIRINOX finally be dethroned?Rita Khoury, Rebecca Ibrahim, Tony Ibrahim, et al.
Anti-Cancer Drugs|August 18, 2017
Response of an ovarian granulosa cell tumor with everolimus and exemestane after initial response to letrozoleTarek Assi, Hampig R Kourie, Elie El Rassy, et al.
Clinics and Research in Hepatology and Gastroenterology|February 21, 2017
Could the combination of Nab-paclitaxel plus gemcitabine salvage metastatic pancreatic adenocarcinoma after folfirinox failure? A single institutional retrospective analysisElie El Rassy, Tarek Assi, Fadi El Karak, et al.
Immunotherapy|July 17, 2018
Do immune checkpoint inhibitors perform identically in patients with weight extremes?Elie El Rassy, Marwan Ghosn, Nathalie Al Rassy, et al.
Pageof 12